Filip F. De Vos
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Adult ependymoma: results from the Dutch Brain Tumour Registry on primary treatment and survival.
Journal: Journal of neuro-oncology
Published: June 16, 2025
Understanding the unmet needs of patients with brain metastases referred for stereotactic radiotherapy and their caregivers: A prospective cohort study.
Journal: Neuro-oncology practice
Published: May 14, 2025
Whole genome sequencing-based analysis of genetic predisposition to adult glioblastoma.
Journal: NPJ genomic medicine
Published: February 20, 2025
Transmural collaboration in palliative care: a feasibility study into structured transfer of care for acutely hospitalized patients
Journal: Nederlands tijdschrift voor geneeskunde
Published: November 13, 2024
The role of molecular biomarkers in recurrent glioblastoma trials: an assessment of the current trial landscape of genome-driven oncology.
Journal: Medical oncology (Northwood, London, England)
Published: August 30, 2024
Recurrent glioblastoma in national guidelines on the diagnosis and treatment of gliomas: A matter of European practice variation.
Journal: Brain & spine
Published: May 17, 2024
Next generation sequencing of high-grade adult-type diffuse glioma in the Netherlands: interlaboratory variation in the primary diagnostic and recurrent setting.
Journal: Journal of neuro-oncology
Published: December 15, 2023
Maximizing Treatment Opportunities: Assessing Protocol Waivers' Impact on Safety and Outcome in the Drug Rediscovery Protocol.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 14, 2023
Potential Adverse Outcomes of Shared Decision Making about Palliative Cancer Treatment: A Secondary Analysis of a Randomized Trial.
Journal: Medical decision making : an international journal of the Society for Medical Decision Making
Published: November 13, 2023
Practice variation in re-resection for recurrent glioblastoma: A nationwide survey among Dutch neuro-oncology specialists.
Journal: Neuro-oncology practice
Published: July 17, 2023
Health-related quality-of-life results from the randomised phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact first-recurrence World Health Organization grade 2 and 3 glioma (European Organization for Research and Treatment of Cancer 26091).
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 11, 2023
Last Updated: 09/26/2026